Jacobs Levy Equity Management, Inc Kodiak Sciences Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $24.7 Billion
- Q3 2024
A detailed history of Jacobs Levy Equity Management, Inc transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 580,783 shares of KOD stock, worth $3.21 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
580,783
Previous 699,158
16.93%
Holding current value
$3.21 Million
Previous $1.64 Million
7.79%
% of portfolio
0.01%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding KOD
# of Institutions
97Shares Held
39MCall Options Held
6.5KPut Options Held
5.8K-
Baker Bros. Advisors LP New York, NY17.3MShares$95.7 Million0.48% of portfolio
-
Black Rock Inc. New York, NY3.85MShares$21.3 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.95MShares$10.8 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.69MShares$9.32 Million0.0% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.02MShares$5.62 Million0.06% of portfolio
About Kodiak Sciences Inc.
- Ticker KOD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,040,200
- Market Cap $288M
- Description
- Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...